Clinical trial Recruiting at 3 sites Interventional Ages 60 and up

Making cognitive screening easy for primary care providers

Official title: Cognitive Screening Made Easy for PCPs - Administrative Supplement

Run by University of Texas at Austin · NCT06928298 · Data updated 2026-11-12

This project will test an automated Spanish‑language risk assessment and brief iPad cognitive screen to help primary care teams find early memory and thinking problems in people aged 60 and older.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Texas at Austin
Academic / other
Locations3 sites (Austin, Texas and 2 other locations)
StatusRecruiting
StartedJune 10, 2025
Main results expectedDecember 31, 2026
Study endsApril 30, 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT06928298 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Spanish‑fluent adults aged 60 or older without a prior dementia diagnosis who can independently use an iPad and attend participating UT clinics in Texas.

Probably not a fit

People with a prior dementia diagnosis, significant motor or visual impairments that prevent independent iPad use, or who are not Spanish‑fluent are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project develops and implements an automated risk assessment and brief cognitive screening app (RACS) tailored for use in primary care settings. The tool is designed to minimize time and effort for clinicians or staff while remaining sensitive to cognitive decline across diverse educational and racial/ethnic backgrounds. The study will enroll Spanish‑fluent adults aged 60+ without a prior dementia diagnosis who can use an iPad and will be conducted at several UT‑affiliated primary care and geriatric clinics in Texas. Key outcomes include feasibility, screening rates, and identification of cognitive impairment during routine visits.

Why it matters

Potential benefit: If successful, the tool could help primary care teams detect cognitive decline earlier so patients can get treatment, support, and planning sooner.

How similar studies have gone: Brief cognitive screening programs in primary care have improved detection rates, but fully automated Spanish‑language tools like this have been less widely tested in real-world clinics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion Criteria:
* Aged 60 years and older;
* Ethnic/racial background consistent with NIH policy
* Male or female
* Fluent in Spanish.

Exclusion Criteria:

* Confounding conditions that could impact ability to participate in the study (e.g., cognitive impairment sufficient to impact ability to follow instructions on the iPad, motor impairment that would prohibit independent use of RACS, poor visual acuity)
* Prior diagnosis of dementia
* Non-Spanish speaking.

Where it's running

  • Family Wellness Clinic
    Austin, Texas, United States
    Recruiting
  • University of Texas Health Austin Primary Care Clinic
    Austin, Texas, United States
    Recruiting
  • UT Health San Antonio's Geriatrics and Supportive Care Clinic
    San Antonio, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Robin C Hilsabeck, PhD — University of Texas Health Sciences Center at San Antonio
  • Study coordinator: Robin C Hilsabeck, PhD
  • Email: hilsabeck@uthscsa.edu
  • Phone: 210-835-8748

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.